June 21, 2012 — TriReme Medical Inc. announced today it received U.S. Food and Drug Administration (FDA) clearance for an expanded matrix of sizes for its Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter. Chocolate is now approved for the percutaneous transluminal treatment of lesions in the peripheral vasculature in balloon diameters from 2 to 4 mm and in balloon lengths of up to 120 mm.
For more information: www.trirememedical.com
April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...
April 04, 2024 
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...
January 18, 2024 
February 25, 2022 
February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...
February 15, 2022 
May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...
May 20, 2021 
The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...
March 16, 2021 
February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...
February 17, 2021 
June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...
June 04, 2020 
February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...
February 24, 2020 
July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...
July 15, 2019